BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 17845474)

  • 21. [Implementation of new Japanese GCP and the quality of clinical trials--from the standpoint of the pharmaceutical industry].
    Ebi O
    Gan To Kagaku Ryoho; 1997 Oct; 24(13):1883-91. PubMed ID: 9350232
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinical drug research from medical ethics and legal perspectives].
    Ornek Büken N; Büken E
    Turk Psikiyatri Derg; 2003; 14(4):289-99. PubMed ID: 14704931
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The adoption of Jardé law modifies the legal framework of clinical research in France].
    Maillols-Perroy AC; Tillet Y
    Therapie; 2012; 67(2):77-87. PubMed ID: 22850095
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cell-based interventions for neurologic conditions: ethical challenges for early human trials.
    Mathews DJ; Sugarman J; Bok H; Blass DM; Coyle JT; Duggan P; Finkel J; Greely HT; Hillis A; Hoke A; Johnson R; Johnston M; Kahn J; Kerr D; Kurtzberg J; Liao SM; McDonald JW; McKhann G; Nelson KB; Rao M; Regenberg A; Siegel AW; Smith K; Solter D; Song H; Vescovi A; Young W; Gearhart JD; Faden R
    Neurology; 2008 Jul; 71(4):288-93. PubMed ID: 18463365
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clinical scientific research with ionizing radiation in Italy. The standards-setting and legal aspects].
    Valle G; Petruccelli L; Podagrosi V; Giustini A; Frusciante V
    Radiol Med; 1999 Sep; 98(3):113-22. PubMed ID: 10575438
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Research ethics committees in Europe: implementing the directive, respecting diversity.
    Hedgecoe A; Carvalho F; Lobmayer P; Raka F
    J Med Ethics; 2006 Aug; 32(8):483-6. PubMed ID: 16877630
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [American and European legislation on bioethics evaluation of clinical experimentation].
    Scuderi G
    Ann Ist Super Sanita; 1998; 34(2):179-85. PubMed ID: 9810739
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The patentability of living organisms between science, law and ethics.
    Frati L; Foà R; Frati P
    Forum (Genova); 1999; 9(3 Suppl 3):8-14. PubMed ID: 10607843
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Does clinical research provide any "direct individual benefit"?].
    Lemaire F
    Med Sci (Paris); 2004 Feb; 20(2):244-7. PubMed ID: 14997448
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Breast cancer research and the European Union Clinical Trials Directive.
    Williams N
    Breast Cancer Res; 2004; 6(4):145-7. PubMed ID: 15217484
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transposition of the Blood Directive into national law--the perspective of Portugal.
    Gonçalves MH; Muon MC; Gonçalves Jd
    Transfus Clin Biol; 2005 Feb; 12(1):18-20. PubMed ID: 15814287
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Italian National Bioethics Committee (CNB) abroad. A bibliography in foreign languages 1990-2007.
    Incorvati G; Petrini C
    J Int Bioethique; 2007; 18(1-2):85-111, 225. PubMed ID: 17902578
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reforming the EU Clinical Trials Directive: streamlining processes or a radical "new" agenda?
    McHale JV
    Eur J Health Law; 2013 Sep; 20(4):363-81. PubMed ID: 23977734
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Medical confidentiality and HIV/AIDS. Ethical-legal perspective].
    Rueff Mdo C
    Acta Med Port; 2004; 17(6):451-64. PubMed ID: 16197857
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of recent legislative bills regarding clinical research on Italian ethics committee activity.
    Porcu L; Poli D; Torri V; Rulli E; Di Tullio MC; Cinquini M; Bajetta E; Labianca R; Di Costanzo F; Nitti D; Floriani I
    J Med Ethics; 2008 Oct; 34(10):747-50. PubMed ID: 18827108
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The conduct of clinical trials for medicinal products in europe in the light of the European clinical trials directive. Review of regulatory and practical aspects in the different countries.
    Dubray C; Maillere P; Spriet A;
    Therapie; 2007; 62(3):193-7, 199-202. PubMed ID: 17803885
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Legal aspects of E-HEALTH.
    Callens S; Cierkens K
    Stud Health Technol Inform; 2008; 141():47-56. PubMed ID: 18953124
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Neuroethics and bioethics--implications of Balkanization controversy].
    Kagawa C
    Brain Nerve; 2009 Jan; 61(1):11-7. PubMed ID: 19177802
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Drug research in Germany--problems and chances--from the viewpoint of the drug industry].
    Weihrauch TR; Baumbauer E
    Arzneimittelforschung; 1998 Nov; 48(11):1047-50. PubMed ID: 9850422
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [A case of fraud in a neurological pharmaceutical clinical trial].
    Hoeksema HL; Troost J; Grobbee DE; Wiersinga WM; van Wijmen FC; Klasen EC
    Ned Tijdschr Geneeskd; 2003 Jul; 147(28):1372-7. PubMed ID: 12892016
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.